Use of misoprostol in myomectomy: a systematic review and meta-analysis

被引:24
作者
Iavazzo, Christos [1 ]
Mamais, Ioannis [2 ]
Gkegkes, Ioannis D. [3 ]
机构
[1] Christie Hosp, Gynaecol Oncol Dept, Manchester, Lancs, England
[2] Univ Athens, Dept Hyg Epidemiol & Med Stat, Athens, Greece
[3] Gen Hosp Attica KAT, Dept Surg 1, Athens, Greece
关键词
Misoprostol; Myomectomy; Fibroid; Myoma; Meta-analysis; BLOOD-LOSS; QUALITY; TRIALS;
D O I
10.1007/s00404-015-3779-x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction Misoprostol, a prostaglandin derivative, reduces blood flow to uterus, facilitating every surgical operation on myometrium. Method PubMed, Scopus and Cochrane databases were systematically searched and five studies met the inclusion criteria for our meta-analysis. Results In total, 283 patients were included. The intention to treat population included 142 patients. The mean age of the patients was 34 years old. The vaginal route of administration was preferred in 117 out of 142 patients and the rectal route in 25 patients. Three studies were included in the analysis regarding duration of operation, estimated blood loss, preoperative/postoperative hemoglobin, transfusions needed and febrile morbidity. No significant difference was observed between vaginal suppository and placebo group concerning the duration of operation, the fall of preoperative hemoglobin, transfusions needed and the febrile morbidity. Regarding the estimated blood loss, the mean difference observed between the misoprostol and placebo groups was -148.55 mL per operation (95 % CI, -233.10 to -64), p < 0.001. As far as the postoperative Hgb, the misoprostol group presented significantly smaller reduction, 0.68 gr/dL per operation (95 % CI, 0.38-0.97), p < 0.001. Conclusion Easy to use, minor or no side effects, and good clinical outcomes are the properties that render misoprostol useful in the realization myomectomy independently of the surgical technique applied.
引用
收藏
页码:1185 / 1191
页数:7
相关论文
共 21 条
[1]   Oxytocin during myomectomy: a randomized study [J].
Agostini, A ;
Ronda, I ;
Franchi, F ;
Bretelle, F ;
Roger, V ;
Cravello, L ;
Blanc, B .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2005, 118 (02) :235-238
[2]   Chemically assisted dissection of tissues: An interesting support in abdominal myomectomy [J].
Benassi, L ;
Lopopolo, G ;
Pazzoni, F ;
Ricci, L ;
Kaihura, C ;
Piazza, F ;
Vadora, E ;
Zini, C .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2000, 191 (01) :65-69
[3]   Vaginal misoprostol enhances intrauterine insemination [J].
Brown, SE ;
Toner, JP ;
Schnorr, JA ;
Williams, SC ;
Gibbons, WE ;
de Ziegler, D ;
Oehninger, S .
HUMAN REPRODUCTION, 2001, 16 (01) :96-101
[4]   Use of a single preoperative dose of misoprostol is efficacious for patients who undergo abdominal myomectomy [J].
Celik, H ;
Sapmaz, E .
FERTILITY AND STERILITY, 2003, 79 (05) :1207-1210
[5]   Clinical Use of Misoprostol in Nonpregnant Women: Review Article [J].
Choksuchat, Chainarong .
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2010, 17 (04) :449-455
[6]   A trial comparing the use of rectal misoprostol plus perivascular vasopressin with perivascular vasopressin alone to decrease myometrial bleeding at the time of abdominal myomectomy [J].
Frederick, Sharifa ;
Frederick, Joseph ;
Fletcher, Horace ;
Reid, Marvin ;
Hardie, Milton ;
Gardner, Wendy .
FERTILITY AND STERILITY, 2013, 100 (04) :1044-1049
[7]  
Goldberg Alisa B, 2003, Curr Womens Health Rep, V3, P475
[8]   Misoprostol to treat postpartum haemorrhage:: a systematic review [J].
Hofmeyr, GJ ;
Walraven, G ;
Gülmezoglu, AM ;
Maholwana, B ;
Alfirevic, Z ;
Villar, J .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2005, 112 (05) :547-553
[9]  
Ikechebelu JI, 2010, NIGER J CLIN PRACT, V13, P154
[10]   Assessing the quality of reports of randomized clinical trials: Is blinding necessary? [J].
Jadad, AR ;
Moore, RA ;
Carroll, D ;
Jenkinson, C ;
Reynolds, DJM ;
Gavaghan, DJ ;
McQuay, HJ .
CONTROLLED CLINICAL TRIALS, 1996, 17 (01) :1-12